Arctic Bioscience AS (OSL:ABS) Dividends per Share : kr0.00 (TTM As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Arctic Bioscience AS Dividends per Share?

Arctic Bioscience AS's dividends per share for the six months ended in Jun. 2024 was kr0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jun. 2024 was kr0.00. Its Dividend Payout Ratio for the six months ended in Jun. 2024 was 0.00. As of today, Arctic Bioscience AS's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Arctic Bioscience AS Dividends per Share Historical Data

The historical data trend for Arctic Bioscience AS's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arctic Bioscience AS Dividends per Share Chart

Arctic Bioscience AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividends per Share

Get a 7-Day Free Trial

Arctic Bioscience AS Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Dividends per Share	Get a 7-Day Free Trial						-	-	-	-	-

Competitive Comparison of Arctic Bioscience AS's Dividends per Share

For the Biotechnology subindustry, Arctic Bioscience AS's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arctic Bioscience AS's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arctic Bioscience AS's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Arctic Bioscience AS's Dividend Yield % falls into.

Save Embed

;

Save Embed

;

Arctic Bioscience AS Dividends per Share Calculation

Dividends paid to per common share.

Arctic Bioscience AS (OSL:ABS) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Arctic Bioscience AS's Dividend Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jun. 2024 )	/	EPS without NRI (Q: Jun. 2024 )
	=	0	/	-0.93
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Arctic Bioscience AS Dividends per Share Related Terms

Thank you for viewing the detailed overview of Arctic Bioscience AS's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Arctic Bioscience AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arctic Bioscience AS (OSL:ABS) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

9TD:Germany

Address

Industrivegen 42, Orsta, NOR, 6155

Website

https://www.arctic-bioscience.com

Arctic Bioscience AS is a Norwegian biotechnology company. The company is focused on developing products and solutions based on bioactive marine compounds. The product portfolio includes nutraceuticals and pharmaceuticals. It is currently developing a novel, cost-efficient oral treatment (HRO350) for mild-to-moderate psoriasis. Its nutraceutical products are sold globally to both B2C and B2B under the Romega brand. The company operates in Norway, Europe, Australia and APAC.

Arctic Bioscience AS Headlines

No Headlines